LOS ANGELES--(BUSINESS WIRE)--Goldberg Law PC announces that a class action lawsuit has been filed in the United States District Court for the Central District of California against Puma Biotechnology, Inc. (“Puma” or the “Company”) (NYSE: PBYI), for alleged violations of the federal securities laws. Investors who purchased or otherwise acquired shares between July 23, 2014 and May 13, 2015, inclusive (the “Class Period”), have until August 3, 2015 to serve as lead plaintiff in the class action.
If you are a shareholder who suffered a loss during the Class Period, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 1404, Marina Del Rey, CA 90292, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
Puma is a biopharmaceutical company that focuses on in-licensing cancer drug candidates that have already undergone or completed clinical testing. The complaint alleges that Puma made false and/or misleading statements and/or failed to disclose in violation of the securities laws that: (1) the Company’s NDA filing would be for a positive early stage breast cancer indication, instead of the previously announced metastatic breast cancer; (2) Puma would need to submit additional safety data from preclinical carcinogenicity studies with its NDA filing, which Puma did not have; (3) the additional studies required would push the timeline for filing the NDA into the first quarter of 2016; (4) the Company overstated results from its Phase III ExteNET Trial; and (5) as a result of the foregoing, Puma lacked a reasonable basis for their positive statements concerning the Company’s outlook, as well as the ongoing ExteNET trial. When the truth was revealed, the stock dropped causing damage to investors.
If you have any questions concerning your legal rights in this case, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
